Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2018-03-05 Regulatory Filings
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Syncona Limited - Nightstar initiates Pivotal Trial in Choroideremia
Regulatory Filings Classification · 90% confidence The document is a press release issued by Syncona Limited, noting an announcement from its portfolio company, Nightstar Therapeutics, regarding the initiation of a Phase 3 pivotal trial for a treatment in Choroideremia. This type of announcement, detailing clinical trial progress and corporate news via PR Newswire, is characteristic of an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is not a full financial report (like 10-K or IR), nor a specific management discussion (MDA), nor a formal voting result (DVA), the most appropriate classification for a time-sensitive, material corporate announcement that isn't strictly earnings-related is often the general regulatory/news category. However, given the focus on clinical trial milestones, it is a significant corporate update. Since there is no specific code for 'Clinical Trial Update' or 'Press Release', and it is not a formal earnings release (ER) which usually contains summarized financial figures, it falls best under the general Regulatory Filings (RNS) category, as it is a broad announcement of material information not covered by other specific codes. It is not short enough to definitively trigger the RPA rule, as it contains substantial detail about the trial, even if it points to the full announcement elsewhere. Therefore, RNS is the best fit for a general corporate news announcement.
2018-03-05 English
Syncona Limited - Directorate Change
Board/Management Information Classification · 99% confidence The document explicitly announces changes in the company's leadership structure. Key phrases include 'Syncona appoints Gian Piero Reverberi as Non-Executive Director', and subsequent announcements regarding the appointment of a Senior Independent Director and the Chair of the Audit Committee. This directly aligns with the definition of Board/Management Information.
2018-03-05 English
Syncona Limited - Monthly Factsheet - January 2018
Fund Information / Factsheet Classification · 98% confidence The document is extremely short (985 characters) and explicitly states, 'Attached is a link to the January 2018 Monthly Fact Sheet for Syncona Limited.' This structure indicates an announcement about the availability of a document rather than the document itself. The title mentions 'Monthly Factsheet' and the content is a brief press release format. Based on the definitions, 'Fund Information / Factsheet' (FS) is the content type, but because this is an announcement linking to the factsheet, it fits the 'Report Publication Announcement' (RPA) category better, as per Rule 2 (The 'MENU VS MEAL' Rule). However, since the content *is* the factsheet summary/link, and 'FS' is specifically defined for 'Fund Information / Factsheet', I must weigh the specific content type against the announcement nature. Given the explicit mention of 'Monthly Fact Sheet' and the definition for FS ('Brief (1-2 page) summary of key company facts, financials, and market info'), FS is the most accurate classification for the *subject matter*. Since the document is an announcement *of* the factsheet, RPA is also plausible. Given the context of financial data classification, identifying the core document type (FS) is often preferred unless the announcement is purely procedural. Since the document *is* the announcement of the factsheet, and RPA is for announcing the publication of reports, RPA is the most precise fit for this short text. Revisiting the definitions: FS is the factsheet itself. RPA is the announcement of publication. This text is the announcement linking to the factsheet. Therefore, RPA is the correct classification based on the 'MENU VS MEAL' rule.
2018-02-27 English
Syncona Limited - Net Asset Value(s)
Net Asset Value Classification · 99% confidence The document explicitly states the title as "Syncona Limited - Net Asset Value(s)". It provides a table showing the NAV as at a specific date (31st January 2018) along with Total Return metrics. This content directly corresponds to the definition of Net Asset Value updates, which is classified as 'NAV'. The document length is very short (982 chars), but since it contains the actual data rather than just announcing the publication of the data, it is classified as the specific report type.
2018-02-27 English
Syncona Limited - Monthly Factsheet - December 2017
Fund Information / Factsheet Classification · 98% confidence The document explicitly titles itself as the 'Syncona Limited - Monthly Factsheet - December 2017'. A factsheet is a brief summary of key company information. This aligns directly with the definition for 'Fund Information / Factsheet' (Code: FS). Although it contains a link to the PDF, the primary content identifies the nature of the attached document as a factsheet, making FS the most specific classification over a general RPA or RNS.
2018-01-30 English
Syncona Limited - Net Asset Value(s)
Net Asset Value Classification · 99% confidence The document explicitly contains the heading "Syncona Limited - Net Asset Value(s)" and presents a table detailing the 'NAV as at 29th December 2017', 'Total Return MTD', and 'Total Return from Inception'. This content directly corresponds to the definition of a Net Asset Value update, which is classified as 'NAV'. The document is short and provides the core data, not an announcement about a report.
2018-01-30 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.